Scarnose International Ltd
Fundamental Score
Scarnose International Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of SCARNOSE across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Robust Profit Growth (100.00%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Strong Profit Growth Track Record (44.65% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
14 factors identified
Below-Average Return on Equity (1.97%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (2.59%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Margin Pressure Concerns (0.18%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Premium Valuation Risk (P/E: 82.04x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Revenue Contraction (-15.98%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Limited Growth History (0.08% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.
Weak Earnings Growth (-54.22% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Negative Free Cash Flow (₹-6.28 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Low Promoter Commitment (0.00%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Scarnose International Ltd
About SCARNOSE
Business Overview
Scarnose International Limited engages in the manufacturing, trading, warehousing, clearing, forwarding, purchasing, selling, and marketing of active pharmaceutical ingredients in India. It also provides oncology drugs, antibiotics, vaccines, pharmaceutical formulations, personal hygiene products, fertilizers, and agricultural chemicals. The company was founded in 2002 and is based in Rajkot, India.
Company Details
Key Leadership
Latest News
SCARNOSE Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Scarnose International Ltd (SCARNOSE)?
As of 02 Jan 2026, 06:51 pm IST, Scarnose International Ltd (SCARNOSE) is currently trading at ₹62.80. The stock has a market capitalization of ₹18.87 (Cr).
Is SCARNOSE share price Overvalued or Undervalued?
SCARNOSE is currently trading at a P/E ratio of 82.04x, compared to the industry average of 20.18x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Scarnose International Ltd share price?
Key factors influencing SCARNOSE's price include its quarterly earnings growth (Sales Growth: -15.98%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Scarnose International Ltd a good stock for long-term investment?
Scarnose International Ltd shows a 5-year Profit Growth of 44.65% and an ROE of 1.97%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.
How does Scarnose International Ltd compare with its industry peers?
Scarnose International Ltd competes with major peers in the Other Textile Products. Investors should compare SCARNOSE's P/E of 82.04x and ROE of 1.97% against the industry averages to determine its competitive standing.
What is the P/E ratio of SCARNOSE and what does it mean?
SCARNOSE has a P/E ratio of 82.04x compared to the industry average of 20.18x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹82 for every ₹1 of annual earnings.
How is SCARNOSE performing according to Bull Run's analysis?
SCARNOSE has a Bull Run fundamental score of 20.6/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does SCARNOSE belong to?
SCARNOSE operates in the Other Textile Products industry. This classification helps understand the competitive landscape and sector-specific trends affecting Scarnose International Ltd.
What is Return on Equity (ROE) and why is it important for SCARNOSE?
SCARNOSE has an ROE of 1.97%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Scarnose International Ltd generates profits from shareholders' equity.
How is SCARNOSE's debt-to-equity ratio and what does it indicate?
SCARNOSE has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is SCARNOSE's dividend yield and is it a good dividend stock?
SCARNOSE offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has SCARNOSE grown over the past 5 years?
SCARNOSE has achieved 5-year growth rates of: Sales Growth 0.08%, Profit Growth 44.65%, and EPS Growth -54.22%.
What is the promoter holding in SCARNOSE and why does it matter?
Promoters hold 0.00% of SCARNOSE shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is SCARNOSE's market capitalization category?
SCARNOSE has a market capitalization of ₹19 crores, placing it in the Small-cap category.
How volatile is SCARNOSE stock?
SCARNOSE has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for SCARNOSE?
SCARNOSE has a 52-week high of ₹N/A and low of ₹N/A.
What is SCARNOSE's operating profit margin trend?
SCARNOSE has a 5-year average Operating Profit Margin (OPM) of 0.18%, indicating the company's operational efficiency.
How is SCARNOSE's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -15.98% and YoY Profit Growth of 100.00%.
What is the institutional holding pattern in SCARNOSE?
SCARNOSE has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.